Jean-Yves Blay

Direttore/Membro del Consiglio presso INNATE PHARMA

Patrimonio netto: 118 $ in data 30/04/2024

61 anni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Jean-Yves Blay

Società	Posizione	Inizio	Fine
INNATE PHARMA	Direttore/Membro del Consiglio	13/12/2017	-
INNATE PHARMA	Independent Dir/Board Member	13/12/2017	-
TRANSGENE	Direttore/Membro del Consiglio	25/05/2022	-
TRANSGENE	Independent Dir/Board Member	25/05/2022	-
Centre Léon Bérard Lyon et Rhône-Alpes	Amministratore Delegato	01/01/2014	-

Società	Posizione	Inizio	Fine
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included.	Presidente	01/01/2019	01/01/2022
European Organisation for Research & Treatment of Cancer	Presidente	01/01/2009	01/01/2012
Académie Nationale de Médecine FCP	Corporate Officer/Principal	01/01/2016	-

Université Claude Bernard Lyon 1

Doctorate Degree

Distribuzione geografica

Francia	7
Belgio	2

Posizioni

Director/Board Member	2
Independent Dir/Board Member	2
President	2

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
INNATE PHARMA	Health Technology
TRANSGENE	Health Technology

Aziende private	4
Centre Léon Bérard Lyon et Rhône-Alpes
Académie Nationale de Médecine FCP	Commercial Services
European Organisation for Research & Treatment of Cancer
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included.	Health Services